Skip to main content
Clinical Trials/NCT04041921
NCT04041921TerminatedNot Applicable

A Multicenter, Prospective, Real World Observational Study for Chronic Total Occlusion

Seung-Jung Park19 sites in 1 country4,006 target enrollmentStarted: January 2010Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
4,006
Locations
19
Primary Endpoint
Composite event of all cause death, myocardial infarction, stroke or all kinds of repeat revascularization

Study Overview

Brief Summary

This study evaluated the long-term outcome of patients with chronic total occlusion treated with percutaneous coronary intervention, medical treatment or coronary artery bypass grafting.

Detailed Description

This study is connected with Decision-CTO trial(NCT01078051). Randomized subjects and registry group subjects from Decision-CTO trial continue 10 years follow-up on this study.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with angina or silent ischemia and documented ischemia
  • Patients with De novo chronic coronary occlusion ≥ 3months and reference diameter ≥ 2.5 mm on coronary angiography
  • Age > 18 years

Exclusion Criteria

  • Refuse to participate in this study

Arms & Interventions

Chronic coronary occlusion patients

≥3 months chronic total occlusion on coronary angiography

Intervention: Percutaneous coronary intervention (Procedure)

Chronic coronary occlusion patients

≥3 months chronic total occlusion on coronary angiography

Intervention: Coronary Artery Bypass Grafting (Procedure)

Chronic coronary occlusion patients

≥3 months chronic total occlusion on coronary angiography

Intervention: Medical treatment (Drug)

Outcomes

Primary Outcomes

Composite event of all cause death, myocardial infarction, stroke or all kinds of repeat revascularization

Time Frame: 10 years

Secondary Outcomes

  • Event rate of all cause death(10 years)
  • Event rate of rehospitalization due to acute coronary syndrome(10 years)
  • Event rate of acute myocardial infarction(10 years)
  • Event rate of stroke(10 years)
  • Event rate of Procedural success(5 days)
  • Event rate of repeat revascularization(10 years)
  • The rate change of left ventricular ejection fraction(10 years)
  • Composite event of death, myocardial, stroke or repeat revascularization(10 years)

Investigators

Sponsor
Seung-Jung Park
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Seung-Jung Park

Professor,University of Ulsan College of Medicine

Asan Medical Center

Study Sites (19)

Loading locations...

Similar Trials